Product Name | NebuSelect™ Recombinant Biotinylated Human IL-18BP, Avi-His-tag |
---|---|
Catalog Number | NBL-240856 |
Alias/Synonyms | IL-18BP; IL-18BP; Igifbp |
Appearance | see COA |
Molecule Weight | Thr31-Gly194 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | O95998-2 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240856-100ug | 100ug | Inquire | Inquire | |
NBL-240856-1mg | 1mg | Inquire | Inquire | |
NBL-240856-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human IL-18BP, Avi-His-tag
Catalog#:
NBL-240856
Description:
NebuSelect™ Recombinant Biotinylated Human IL-18BP, Avi-His-tag(Cat#NBL-240856) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Thr31-Gly194.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 20.5 kDa. Due to glycosylation, the protein migrates to 52-65 kDa based on Bis-Tris PAGE result.
Target Name:
IL-18BP; IL-18BP; Igifbp
Target Information:
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice.
Amino Acid Sequence:
Thr31-Gly194
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.